Kuri Canine Scott Syndrome (CSS)

Understanding Canine Scott Syndrome

Canine Scott Syndrome is a rare inherited bleeding disorder that affects dogs, characterized by a deficiency in platelet function. Unlike other bleeding disorders that result from a decrease in platelet count, Scott Syndrome involves a defect in the ability of platelets to expose phosphatidylserine on their surface, which is essential for proper blood clotting. This defect impairs the blood's ability to form stable clots, leading to an increased risk of bleeding episodes.

Genetic Basis of Canine Scott Syndrome

The condition is inherited in an autosomal recessive manner, meaning that a dog must inherit two copies of the mutated gene—one from each parent—to be affected. Carriers, with only one copy of the mutation, usually do not exhibit symptoms but can pass the gene to offspring. The genetic mutation responsible for Scott Syndrome affects the pathways involved in platelet activation and phospholipid scrambling, crucial processes in the coagulation cascade.

Symptoms and Clinical Presentation

Dogs affected by Scott Syndrome typically present with easy bruising, spontaneous bleeding, prolonged bleeding after injuries or surgeries, and in some cases, bleeding into joints or tissues. The severity of symptoms can vary depending on the extent of platelet dysfunction. Often, affected dogs may not show signs until an injury occurs or during surgical procedures, when bleeding complications become evident.

Importance of DNA Testing for Canine Scott Syndrome

The DNA test for Scott Syndrome plays a vital role in identifying carriers and affected dogs, facilitating informed breeding decisions to prevent the spread of the disorder. Early diagnosis through genetic testing allows veterinarians and breeders to implement appropriate management strategies, such as avoiding trauma, planning for potential bleeding complications during surgeries, and reducing the incidence of affected puppies in the population. It also helps in understanding the prevalence of the condition within specific breeds or bloodlines.

Implications of the Test Results

Testing can confirm whether a dog is affected, a carrier, or clear of the mutation. An affected dog requires careful medical management to prevent bleeding episodes, especially during surgeries or injuries. Carriers are generally asymptomatic but should be considered in breeding programs to prevent passing the mutation to offspring. Dogs that test clear are not at risk of developing or passing on the disorder, contributing to healthier bloodline management.

Whakamutunga

DNA testing for Canine Scott Syndrome is an essential tool for responsible breeding and health management. By accurately identifying affected dogs and carriers, owners and breeders can make informed decisions that promote canine health and reduce the prevalence of this inherited bleeding disorder in the dog population.

He momo kua tohua mo te whakamatautau: Canine Scott Syndrome (CSS)

• American White Shepherd Dog
• Beagle
• Chinese Crested
• German Shepherd Dog
• Shiloh Shepherd
• Swiss White Shepherd Dog

🧬 Interpretation of genotypes CSS

Matapaea te uri

Tohutoro